Fetal supraventricular tachycardia: Case report and review of the literature

Yozgat Y., Ozdemir R., Kurtulmus S., Doksoz O., Guven B., KaradenIz C., ...More

IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI, vol.3, no.2, pp.127-132, 2013 (ESCI) identifier

  • Publication Type: Article / Review
  • Volume: 3 Issue: 2
  • Publication Date: 2013
  • Doi Number: 10.5222/buchd.2013.127
  • Journal Name: IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.127-132
  • Keywords: Fetal tachyarrhythmia, fetal supraventricular tachycardia, sotalol, digoxin, HYDROPS-FETALIS, THERAPY, AMIODARONE, DIAGNOSIS
  • Kütahya Health Sciences University Affiliated: No

Abstract

Fetal tachyarrhythmias may occur in 0.4-0.6% of pregnancies. Supraventricular tachycardia (SVT) is the most frequently reported fetal tachyarrhythmia. Fetal SVT is a rhythm disturbance characterized by 1:1 atrioventricular conduction at a rate between 220 and 300 beats per minute. Digoxin is the most common first-line antiarrhythmic agent for fetal SVT, but there is no consensus on the most effective second-line therapeutic agent. Herein, we report a case of SVT at her 23rd week of gestation in whom digoxin and sotalol combination therapy failed. Management guidelines in the literature were also reviewed.